mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.06 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.06 |